The U.S. President’s Malaria Initiative (PMI) supports 24 partner countries in sub-Saharan Africa and three programs in the Greater Mekong Subregion in Southeast Asia to control and eliminate malaria. PMI delivers cost-effective, life-saving malaria interventions—such as insecticide-treated bed nets, indoor residual spraying, and essential medicines—alongside catalytic technical and operational assistance to equip and empower partner countries to end malaria. PMI is a multi-agency initiative, led by USAID and co-implemented with the U.S. Centers for Disease Control and Prevention (CDC) within the U.S. Department of Health and Human Services (HHS). PMI also has strong support from, and collaborates closely with, the Department of Defense; the National Institutes of Health; Peace Corps; and other U.S. departments, agencies, and programs. To learn more about the U.S. President’s Malaria Initiative, visit pmi.gov.
Results
Today, PMI’s programs benefit at least 700 million people at risk of malaria. Since 2006, in countries where PMI works, global efforts have supported a 29 percent drop in malaria case rates and a 60 percent decline in malaria death rates. Child mortality has also fallen on average by 44% across PMI-supported African countries. See PMI's FY 2020 Annual Report for more information on impact and results.
